NEW YORK – Purdue Pharma LP’s settlement talks over the drugmaker’s opioid painkillers have stalled over how much money the family that owns the company is willing to pay, according to people familiar with the negotiations. The Sacklers, Purdue’s owners, have rejected demands by state attorneys general that they guarantee $4.5 billion as part of a…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.